NIM811 downregulates transforming growth factor‑β signal transduction in vivo and in vitro.

Liver fibrosis is the common histological feature of a number of chronic liver diseases, and leads to cirrhosis and hepatocellular carcinoma (HCC). It has been demonstrated that N‑methyl‑4‑isoleucine cyclosporine (NIM811) attenuates CCl4‑induced liver fibrosis and inflammation in rats. The present study investigated whether NIM811 downregulated transforming growth factor (TGF)‑β signaling in rats with CCl4‑induced liver fibrosis and in HSC‑T6 cells. Liver tissues were obtained from rats with CCl4‑induced liver fibrosis, with or without NIM811 treatment. HSC‑T6 cells were cultured with or without NIM811 for 18 h under serum‑free conditions. Expression of collagen I, α‑smooth muscle actin (α‑SMA), TGF‑β1, TGF‑β receptor I (TβR‑I) and TGF‑β pathway downstream signaling molecules were measured by reverse transcription‑quantitative polymerase chain reaction and/or western blotting. Collagen I and TGF‑β1 content in the cell supernatant was measured by ELISA. NIM811 profoundly inhibited collagen I, α‑SMA, TGF‑β1 and TβR‑I expression in the liver of CCl4‑treated rats. Phosphorylation of Smad2, 3 and 1/5/8 was decreased in the liver of NIM811‑treated groups, accompanied by increased In addition, Smad7 expression compared with the CCl4‑treated rats. NIM811 inhibited collagen I, TGF‑β1 and TβR‑I expression in HSC‑T6 cells. Smad1 mRNA and phospho‑Smad1/5/8 protein levels decreased following NIM811 treatment, accompanied by increased Smad7 expression in HSC‑T6 cells compared with normal controls. Furthermore, NIM811 also inhibited collagen I mRNA expression in the liver of rats with CCl4‑induced liver fibrosis and in HSC‑T6 cells. The results suggest that the antifibrotic effect of NIM811 was due to the inhibition of TGF‑β1 and its downstream signaling molecules.

[1]  J. Jia,et al.  N‐methyl‐4‐isoleucine cyclosporine attenuates CCl4‐induced liver fibrosis in rats by interacting with cyclophilin B and D , 2011, Journal of gastroenterology and hepatology.

[2]  S. Friedman.  Hepatic fibrosis -- overview. , 2008, Toxicology.

[3]  R. Bataller,et al.  Cytokines and renin-angiotensin system signaling in hepatic fibrosis. , 2008, Clinics in liver disease.

[4]  Bao-en Wang,et al.  Down-regulation of transforming growth factor beta 1/activin receptor-like kinase 1 pathway gene expression by herbal compound 861 is related to deactivation of LX-2 cells. , 2008, World journal of gastroenterology.

[5]  S. Friedman,et al.  Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.

[6]  T. Theruvath,et al.  Minocycline and N‐methyl‐4‐isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition , 2007, Hepatology.

[7]  S. Friedman.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.

[8]  A. Gressner,et al.  Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. , 2007, Journal of hepatology.

[9]  K. Kotoh,et al.  NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[10]  Christopher J. Parsons,et al.  Molecular mechanisms of hepatic fibrogenesis , 2007, Journal of gastroenterology and hepatology.

[11]  A. Gressner,et al.  Pro-fibrogenic potential of PDGF-D in liver fibrosis. , 2007, Journal of hepatology.

[12]  T. Theruvath,et al.  NIM811, a Mitochondrial Permeability Transition Inhibitor, Prevents Mitochondrial Depolarization in Small‐for‐Size Rat Liver Grafts , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  Y. Inagaki,et al.  Emerging insights into Transforming growth factor β Smad signal in hepatic fibrogenesis , 2007, Gut.

[14]  H. Okano,et al.  Bone marrow–derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice , 2007, Hepatology.

[15]  Z. Zhonga,et al.  NIM 811 , a Mitochondrial Permeability Transition Inhibitor , Prevents Mitochondrial Depolarization in Small-for-Size Rat Liver Grafts , 2007 .

[16]  C. Lechuga,et al.  PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[17]  F Verrecchia,et al.  [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.

[18]  S. Dooley,et al.  Id1 is a critical mediator in TGF‐β–induced transdifferentiation of rat hepatic stellate cells , 2006, Hepatology.

[19]  S. Dooley,et al.  TGF-β/Smad Signaling in the Injured Liver , 2006 .

[20]  S. Dooley,et al.  TGF-beta/Smad signaling in the injured liver. , 2006, Zeitschrift fur Gastroenterologie.

[21]  K. Miyazono,et al.  Two major Smad pathways in TGF‐β superfamily signalling , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[22]  M. Pinzani.  PDGF and signal transduction in hepatic stellate cells. , 2002, Frontiers in bioscience : a journal and virtual library.

[23]  John J Lemasters,et al.  Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. , 2002, Molecular pharmacology.

[24]  Jeffrey L. Wrana,et al.  Signal Transduction by the TGF-β Superfamily , 2002, Science.

[25]  J. Wrana,et al.  Signal transduction by the TGF-beta superfamily. , 2002, Science.

[26]  E. Hara,et al.  Id proteins in cell cycle control and cellular senescence , 2001, Oncogene.

[27]  F. Marra,et al.  Cytokine Receptors and Signaling in Hepatic Stellate Cells , 2001, Seminars in liver disease.

[28]  K. Miyazono,et al.  Divergence and convergence of TGF‐β/BMP signaling , 2001, Journal of cellular physiology.

[29]  Fumiko Itoh,et al.  Signaling of transforming growth factor‐β family members through Smad proteins , 2000 .

[30]  S. Dooley,et al.  Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts , 2000, Hepatology.

[31]  M. Goumans,et al.  Signaling of transforming growth factor-beta family members through Smad proteins. , 2000, European journal of biochemistry.

[32]  C. Heldin,et al.  Transforming Growth Factor β1 Induces Nuclear Export of Inhibitory Smad7* , 1998, The Journal of Biological Chemistry.

[33]  B. Hall,et al.  Signal transduction and TGF-beta superfamily receptors. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[34]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[35]  S. Friedman,et al.  Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. , 1994, The Journal of clinical investigation.

[36]  S. Friedman,et al.  Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo. , 1994, The Journal of biological chemistry.

[37]  R. Aebersold,et al.  Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides. , 1994, The Biochemical journal.

[38]  W. Border,et al.  Transforming growth factor beta in tissue fibrosis. , 1994, The New England journal of medicine.

[39]  S. Milani,et al.  Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. , 1993, Gastroenterology.